TrialThe Journal of clinical endocrinology and metabolism2023

Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial.

Elizabeth Roof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.